Leading nutraceutical contract manufacturer secures prime Irvine facility near John Wayne Airport, marking its tenth operational site and further elevating its gold-standard quality compliance.

SANTA ANA, Calif., Sept. 9, 2026 /PRNewswire/ — Robinson Pharma, Inc. (RPI), a premier full-service contract manufacturer of dietary supplements and nutraceuticals, today announced a milestone expansion of its Southern California footprint. Through a strategic real estate acquisition strategy totaling more than $115 million across two key properties secured just eight months apart, the company has substantially advanced its production and logistics capabilities.

To cap this momentum, Robinson Pharma has officially received United States Pharmacopeia (USP) certification following its latest facility launch, solidifying its status as an industry leader in quality assurance.

Strategic $115M+ Real Estate Expansion
The dual acquisitions represent a massive scale-up for the company, expanding its total operational space to meet soaring global demand for custom supplement formulations:

• The First Acquisition (December 2025): Robinson Pharma kicked off its current expansion phase by acquiring a newly constructed 82,241-square-foot industrial building at 3130 South Fairview Street in Santa Ana for approximately $40.7 million.
• The Recent Airport-Area Purchase (August 2026): Just eight months later, Robinson Pharma completed its largest-ever real estate deal: a $75 million purchase of a massive 261,000-square-foot industrial facility located at 2323 Main Street in Irvine. Situated in a highly coveted logistical corridor right by John Wayne Airport, this site establishes a major new foothold for the company outside of its traditional Santa Ana hub.

Combined, these two facilities represent a capital investment exceeding $115 million, introducing nearly 350,000 square feet of state-of-the-art manufacturing and warehousing space into Robinson Pharma’s network. The new Irvine location serves as the company’s 10th warehouse and production hub, bringing its total regional footprint well beyond one million square feet.

Achieving the Gold Standard: USP Certification
Following the close of the Irvine airport property, Robinson Pharma underwent rigorous audits to secure prestigious USP certification. This milestone enhances an already robust compliance portfolio that includes registrations and audits from the FDA, NSF GRMA, UL GMP, SQF, CCOF, and SCCI. The addition of USP certification offers health and wellness brands unmatched verification that RPI’s manufacturing lines, raw material controls, and finished product standards meet the absolute highest thresholds of purity and consistency.

“Our massive infrastructure investment over the last eight months reflects our absolute commitment to our clients’ growth and the safety of the consumers they serve,” said a Robinson Pharma representative. “Securing the Irvine airport facility gives us the physical capacity to scale throughput across all of our core formats—including softgels, tablets, capsules, powders, and liquids. Paired with our newly finalized USP certification, health brands can scale confidently with a manufacturing partner that operates at the pinnacle of efficiency and regulatory compliance.”

About Robinson Pharma
Founded in 1989, Robinson Pharma is an established manufacturer for the nutraceutical industry. Known for its extensive production capacity, competitive pricing, and quality standards, the company manufactures a comprehensive range of dietary supplements, including softgels, veggie softgels, tablets, capsules, powders, and liquids. With cutting-edge facilities and a focus on custom formulations and custom packaging, Robinson Pharma is one of the largest supplement manufacturers in the US.

For more information about Robinson Pharma’s expanded manufacturing capabilities and to learn how the company can help your supplement manufacturing needs, please visit www.robinsonpharma.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/robinson-pharma-accelerates-southern-california-expansion-with-over-115-million-in-property-acquisitions-and-earns-usp-certification-302874119.html

SOURCE Robinson Pharma, Inc.